Therapeutic Potential of Extracellular Vesicles in Hypertension-Associated Kidney Disease

25Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

Hypertension-mediated organ damage frequently includes renal function decline in which several mechanisms are involved. The present review outlines the state of the art on extracellular vesicles in hypertension and hypertension-related renal damage. Emerging evidence indicates that extracellular vesicles, small vesicles secreted by most cell types and body fluids, are involved in cell-to-cell communication and are key players mediating biological processes such as inflammation, endothelial dysfunction or fibrosis, mechanisms present the onset and progression of hypertension-associated kidney disease. We address the potential use of extracellular vesicles as markers of hypertension-mediated kidney damage severity and their application as therapeutic agents in hypertension-associated renal damage. The capacity of exosomes to deliver a wide variety of cargos to the target cell efficiently makes them a potential drug delivery system for treatment of renal diseases.

Cite

CITATION STYLE

APA

Martinez-Arroyo, O., Ortega, A., Redon, J., & Cortes, R. (2021, January 1). Therapeutic Potential of Extracellular Vesicles in Hypertension-Associated Kidney Disease. Hypertension. Lippincott Williams and Wilkins. https://doi.org/10.1161/HYPERTENSIONAHA.120.16064

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free